Edwin Reisz Sells 59,217 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Edwin Reisz sold 59,217 shares of the business’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $7.38, for a total value of $437,021.46. Following the completion of the transaction, the insider owned 1,507,826 shares in the company, valued at $11,127,755.88. This trade represents a 3.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Aveanna Healthcare Stock Performance

Aveanna Healthcare stock traded up $0.02 during mid-day trading on Thursday, reaching $7.42. 3,877,110 shares of the company were exchanged, compared to its average volume of 938,081. The firm’s 50-day simple moving average is $8.48 and its two-hundred day simple moving average is $8.44. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.67 and a twelve month high of $10.32. The firm has a market cap of $1.55 billion, a PE ratio of 20.61 and a beta of 2.06. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds have recently bought and sold shares of the company. Quantbot Technologies LP acquired a new position in Aveanna Healthcare during the second quarter worth $43,000. MQS Management LLC purchased a new position in shares of Aveanna Healthcare in the second quarter valued at $59,000. Belvedere Trading LLC acquired a new position in shares of Aveanna Healthcare during the 2nd quarter worth $62,000. Oxford Asset Management LLP purchased a new stake in shares of Aveanna Healthcare in the 2nd quarter worth about $64,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at about $68,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AVAH has been the topic of several recent research reports. Barclays boosted their price objective on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. Raymond James Financial reiterated an “outperform” rating and set a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. Royal Bank Of Canada raised their price target on Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a report on Thursday, January 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday, December 29th. Finally, William Blair initiated coverage on Aveanna Healthcare in a research report on Monday, December 8th. They issued an “outperform” rating for the company. Five investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Aveanna Healthcare presently has an average rating of “Hold” and a consensus target price of $11.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.